News & Events



news_id: 48

AutekBio Received $100M Investment

AutekBio recently signed a deal securing $100 million in venture capital from private and government sources. Contributing to the capital raise were SUMA Ventures and Beijing E-Town Harvest International Capital Management Corporation, Beijing’s Municipal Government’s venture capital group.

The new joint venture will build a world class R&D and manufacturing center in southern Beijing to service international biologic developments, with combined volumes of bioreactors up to 20,000 liters in multiple production lines (trains).

AutekBio was founded in 2006. One year after its beginning, the company singed a biologic CMO contract with Jiangsu Hengrui Pharmaceutical Corp. for a cancer MAb drug that was one of the largest CMO contracts in China’s pharmaceutical industry.

AutekBio Received $100M Investment

FOXO3A: The Longivity Gene Also Found in Chinese

BayHelix held its annual meeting

Vitamin C: key discovery of iPS transformation

Soy may help breast cancer survivors

PPD Purchase BioDuro and Expand its Operation in China

Novartis announced USD 1 billion investment in R&D in China

中国航天之父钱学森今日在京逝

Discovery of telomerase won 2009 nobel Prize in Physiology or Medicine

Dr. Lin He recieved 2009 MacArthur "genius" Fellows Award for her research in miRNA

FDA Approved H1N1 Vaccines

中国首批H1N1疫苗批准通过

Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |